Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D001798:Blood Proteins / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000209:etiology / Q000276:immunology*; D002648:Child; D003168:Complement Fixation Tests; D005260:Female; D006506:Hepatitis A / Q000150:complications; D006511:Hepatitis B Antigens / Q000032:analysis; D006515:Hepatitis B virus; D006801:Humans; D005779:Immunodiffusion; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications / Q000209:etiology / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D014454:Uganda
D001798:Blood Proteins; D006511:Hepatitis B Antigens